Alvogen recalls Thyro-Tabs 150mcg tablets due to a reported mix-up with 88mcg tablets. Affected units contain Lot # MHA21825, expiring Dec 2027. Check your bottle for correct dosage.
Alvogen is recalling Thyro-Tabs 150mcg tablets after a pharmacy reported a mix-up where some bottles contained 88mcg tablets instead of the intended 150mcg. This could lead to incorrect thyroid hormone dosing if taken without checking the actual tablet strength. Read more at govinfonow.com/recall/31565-alvogen-thyro-tabs-150mcg-tablets-recall-product-mix-up-risk.
“Alvogen Thyro-Tabs 150mcg Tablets Recall: Product Mix-Up Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31565-alvogen-thyro-tabs-150mcg-tablets-recall-product-mix-up-risk. Based on FDA recall #D-0259-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0259-2026%22&limit=1).
The FDA announced on December 31, 2025, that Alvogen, Inc. is recalling Thyro-Tabs Levothyroxine Sodium Tablets, USP, 150mcg due to a product mix-up hazard. The agency stated the recall is voluntary and ongoing.
A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of the labeled 150 mcg tablets. The FDA classified the recall as Class II.
Context
GovInfoNow's records show Alvogen, Inc. has 9 other recalls on record since August 28, 2014. Other recent recalls of similar products include Macleods Levothyroxine Tablets Recall (February 26, 2026), Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), and Accord Healthcare Levothyroxine Tablets Recall (August 6, 2026).
How to tell if you have this one
Check your Thyro-Tabs bottle for the lot number MHA21825. The product expires December 31, 2027. Only the specific lot was reported to have the mix-up.
Brand
Alvogen
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Tablet Strength
Verify the tablet strength on your bottle; if it shows 88mcg instead of 150mcg, contact your pharmacy immediately.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 21 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0259-2026 (December 31, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0259-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.